Want to see BNR full AI Analyst Report?
Burning Rock Biotech (BNR) Income Statement
Burning Rock Biotech Income Statement
Last quarter (Q2 2026), Burning Rock Biotech's total revenue was $134.91M, a decrease of 9.19% from the same quarter last year. In Q2, Burning Rock Biotech's net income was $-18.43M. See Burning Rock Biotech’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 539.57M | $ 515.82M | $ 537.43M | $ 563.24M | $ 507.86M | |
| $ 402.91M | $ 362.40M | $ 363.23M | $ 380.04M | $ 364.15M | |
| $ 457.76M | $ 719.96M | $ 1.03B | $ 1.36B | $ 1.16B | |
| Depreciation and Amortization | $ 21.76M | $ 52.20M | $ 133.40M | $ 124.10M | $ 47.77M |
| $ -32.00M | $ -270.23M | $ -517.90M | $ -845.15M | $ -746.50M | |
| $ -54.84M | $ -357.56M | $ -669.32M | $ -980.41M | $ -797.06M | |
| $ 1.05M | $ 16.82M | $ 18.02M | $ 11.16M | $ 1.27M | |
| $ -53.79M | $ -340.74M | $ -651.30M | $ -969.25M | $ -795.80M | |
| $ -55.35M | $ -346.63M | $ -653.69M | $ -971.23M | $ -796.70M | |
| Per Share Metrics | |||||
| Basic EPS | $ -49.60 | $ -33.67 | $ -63.84 | $ -93.47 | $ -76.45 |
| Diluted EPS | $ -49.60 | $ -33.67 | $ -63.84 | $ -93.47 | $ -76.45 |
| Weighted Average Shares Outstanding | 1.08M | 10.29M | 10.24M | 10.39M | 10.42M |
| Weighted Average Shares Outstanding (Diluted) | 1.08M | 10.29M | 10.24M | 10.39M | 10.42M |
Currency in CNY
